CLBT Cellebrite DI Ltd

  1. Stocks
  2. Technology
  3. NASDAQ: CLBT

Price (delayed)

$10.88

Market cap

$2.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.43

Enterprise value

$2.06B

Cellebrite is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and ...

Highlights
The gross profit has increased by 24% YoY and by 6% QoQ
CLBT's revenue is up by 20% YoY and by 6% QoQ
The debt has grown by 18% from the previous quarter but it has contracted by 8% YoY
The net income has dropped by 170% year-on-year and by 27% since the previous quarter
Cellebrite DI's EPS has shrunk by 167% YoY and by 43% QoQ
Sector: Technology
Industry: Software - Infrastructure
Website: https://www.cellebrite.com
Peers: PGY PHR PHUN

Key stats

What are the main financial stats of CLBT
Market
Shares outstanding
205.3M
Market cap
$2.23B
Enterprise value
$2.06B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
60.92
Price to sales (P/S)
6.36
EV/EBIT
61.93
EV/EBITDA
47.59
EV/Sales
6.33
Earnings
Revenue
$325.11M
EBIT
$33.24M
EBITDA
$43.25M
Free cash flow
$94.14M
Per share
EPS
-$0.43
Free cash flow per share
$0.5
Book value per share
$0.18
Revenue per share
$1.71
TBVPS
$2.61
Balance sheet
Total assets
$532.89M
Total liabilities
$498.67M
Debt
$14.13M
Equity
$34.21M
Working capital
$168.26M
Liquidity
Debt to equity
0.41
Current ratio
1.66
Quick ratio
1.5
Net debt/EBITDA
-4.06
Margins
EBITDA margin
13.3%
Gross margin
83.6%
Net margin
-24.9%
Operating margin
10.2%
Efficiency
Return on assets
-17.6%
Return on equity
-251.3%
Return on invested capital
40.5%
Return on capital employed
11.9%
Return on sales
10.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CLBT stock price

How has the Cellebrite DI stock price performed over time
Intraday
1.59%
1 week
3.92%
1 month
-8.34%
1 year
103.36%
YTD
25.64%
QTD
-1.81%

Financial performance

How have Cellebrite DI's revenue and profit performed over time
Revenue
$325.11M
Gross profit
$271.88M
Operating income
$33.24M
Net income
-$81.1M
Gross margin
83.6%
Net margin
-24.9%
The net income has dropped by 170% year-on-year and by 27% since the previous quarter
The net margin has plunged by 158% YoY and by 19% from the previous quarter
The gross profit has increased by 24% YoY and by 6% QoQ
CLBT's revenue is up by 20% YoY and by 6% QoQ

Growth

What is Cellebrite DI's growth rate over time

Valuation

What is Cellebrite DI stock price valuation
P/E
N/A
P/B
60.92
P/S
6.36
EV/EBIT
61.93
EV/EBITDA
47.59
EV/Sales
6.33
Cellebrite DI's EPS has shrunk by 167% YoY and by 43% QoQ
The equity has dropped by 54% year-on-year and by 10% since the previous quarter
The stock's price to book (P/B) is 27% more than its last 4 quarters average of 47.9
The P/S is 38% above the last 4 quarters average of 4.6
CLBT's revenue is up by 20% YoY and by 6% QoQ

Efficiency

How efficient is Cellebrite DI business performance
CLBT's ROE has plunged by 179% YoY and by 65% from the previous quarter
CLBT's return on assets has dropped by 153% year-on-year and by 18% since the previous quarter
CLBT's return on invested capital has surged by 51% since the previous quarter
Cellebrite DI's return on sales has increased by 34% QoQ

Dividends

What is CLBT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLBT.

Financial health

How did Cellebrite DI financials performed over time
The total assets is 7% more than the total liabilities
Cellebrite DI's total liabilities has soared by 51% YoY and by 14% from the previous quarter
The total assets has grown by 32% YoY and by 12% from the previous quarter
The debt is 59% less than the equity
The debt to equity has surged by 95% year-on-year and by 28% since the previous quarter
The equity has dropped by 54% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.